Investing Ideas
/
Vietnamese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Vietnamese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

2 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	PMC New Pharmedic Pharmaceutical Medicinal	₫113,800.00	1.6%	44.1%	₫1.1t	n/a	PE13.3x	n/a	16.8%
	MED Mediplantex National Pharmaceutical	₫26,000.00	0%	0.8%	₫322.7b	n/a	PE19.7x	n/a	1.9%

Page 1 of 1